Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial

Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.2%
    Check dated 2025-06-13T19:16:12.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.2%
    Check dated 2025-06-06T17:28:11.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    3%
    Check dated 2025-05-30T13:07:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.5%
    Check dated 2025-05-23T11:41:26.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T23:54:19.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.15.0) and the removal of detailed study criteria and descriptions related to FG-4592 and rosiglitazone.
    Difference
    16%
    Check dated 2025-04-17T11:03:46.000Z thumbnail image

Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.